X0202 4 2008-05-06 0 0001059790 POZEN INC /NC POZN 0001298628 Hodges William L C/O POZEN INC. 1414 RALEIGH RD, SUITE 400 CHAPEL HILL NC 27517 0 1 0 0 Sr. VP Finance, CFO Stock Option (Right to Buy) 14.45 2008-05-06 4 A 0 16600 0 A 2018-05-06 Common Stock 16600 16600 D The options vest as follow: twenty-five percent (25%) will vest upon the acceptance by the U.S. Food and Drug Administration (FDA) of the New Drug Application (NDA) for PN 400; the remaining seventy-five (75%) will vest upon the receipt by the Company of an action letter from the FDA indicating approval of the NDA for PN 400. The options also include provisions that require satisfactory employee performance prior to vesting. William L. Hodges 2008-05-08